EPJ Nuclear Sciences & Technologies is a prominent Open Access journal published by EDP Sciences S A, focusing on the vital fields of Nuclear and High Energy Physics, Nuclear Energy and Engineering, and Energy Engineering and Power Technology. Launched in 2015, this journal provides a platform for researchers, students, and professionals to disseminate cutting-edge research and innovations that address the challenges and opportunities in nuclear sciences, a field of critical importance in today’s energy landscape. With an ISSN of 2491-9292 and an evolving impact reflected in its 2023 Q3 quartile rankings across several relevant categories, EPJ Nuclear Sciences & Technologies is committed to promoting high-quality, peer-reviewed research accessible to a global audience. Its dedicated focus on enhancing knowledge transfer and international collaboration makes it an essential resource for anyone engaged in nuclear sciences and technologies.

CURRENT OPINION IN CELL BIOLOGY, published by CURRENT BIOLOGY LTD, serves as a vital resource for scholars and professionals in the dynamic field of cell biology. With a solid Q1 ranking and impressive Scopus ranking of #33 out of 285 in the category of Cell Biology, this journal is recognized for its high impact and relevance among its peers, boasting an excellent percentile ranking of 88th. Established in 1989, it provides insightful reviews and perspectives that capture the latest developments and emergent trends in cellular research, making it indispensable for those aiming to deepen their understanding of cellular mechanisms and innovations. While the journal does not offer open access, its carefully curated content ensures that subscribers receive top-tier scholarly discourse. Situated in the heart of the United Kingdom, CURRENT OPINION IN CELL BIOLOGY continues to shape the conversation in a field that is critical to advancements in biochemistry, genetics, and molecular biology.

NUCLEAR PHYSICS A, published by Elsevier, is a leading international journal dedicated to the fields of Nuclear and High Energy Physics. With an ISSN of 0375-9474 and E-ISSN 1873-1554, the journal has been pivotal in advancing research since its inception in 1967 and is set to continue influencing the discipline through 2025. It holds a commendable Q2 classification in the 2023 category of Nuclear and High Energy Physics, ranking 32nd out of 87 journals in its field according to Scopus, placing it in the 63rd percentile. NUCLEAR PHYSICS A provides valuable insights and disseminates cutting-edge research, aiding researchers, professionals, and students in their academic and practical pursuits. Though it does not currently offer open access, the journal remains a vital resource for those engaged in the exploration of nuclear phenomena and theoretical advancements in high-energy physics.

RNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.

NATURE STRUCTURAL & MOLECULAR BIOLOGY is a leading journal published by NATURE PORTFOLIO, dedicated to advancing the field of molecular and structural biology since its inception in 1998. With an impressive impact factor that places it in the Q1 quartile across both the Molecular Biology and Structural Biology categories, this journal is pivotal for researchers and professionals seeking to publish innovative and high-impact results. Its Scopus ranking further highlights its elite status, with a remarkable 98th percentile for Structural Biology and 95th for Molecular Biology. While the journal does not currently offer open access, it continues to foster a rich discourse among scientists by providing a platform for the dissemination of groundbreaking research. Located in the United Kingdom and operated from Berlin, the journal's commitment to excellence positions it as an indispensable resource for students, researchers, and practitioners in the realms of biochemistry, genetics, and molecular biology.

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

ATOMIC DATA AND NUCLEAR DATA TABLES, published by Academic Press Inc Elsevier Science, is a leading journal in the fields of atomic and molecular physics, as well as nuclear and high energy physics. With an ISSN of 0092-640X and an E-ISSN of 1090-2090, this esteemed journal has been providing comprehensive data tables and significant research insights since its establishment in 1969. Spanning until 2024, it continues to serve as an invaluable resource for researchers and professionals aiming to deepen their understanding of atomic interactions and nuclear processes. Holding a commendable Q2 ranking in both relevant categories, it is recognized for its impact, reflected in Scopus rankings, where it ranks 25th out of 87 in Nuclear and High Energy Physics, and 87th out of 224 in Atomic and Molecular Physics. While it does not offer open access, the journal remains a crucial repository for high-quality data essential for scientific endeavors and advancements in these complex fields.

NUCLEAR TECHNOLOGY is a leading academic journal published by TAYLOR & FRANCIS INC, dedicated to the expansive field of nuclear science and engineering. With a robust ISSN of 0029-5450 and an E-ISSN of 1943-7471, this journal provides invaluable insights and cutting-edge research from 1971 to 2024. Positioned in the esteemed Q2 category for Condensed Matter Physics, Nuclear and High Energy Physics, and Nuclear Energy and Engineering, it boasts respectable Scopus rankings, underscoring its impact and relevance within the academic community. NUCLEAR TECHNOLOGY serves as a crucial platform for researchers, professionals, and students, fostering an exchange of knowledge that advances the understanding and application of nuclear technologies. While it operates on a subscription model, this journal remains a vital resource for those aiming to contribute to or stay at the forefront of developments in nuclear technology.

GENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.

Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.